78 followers
417 followers
Publicado un EECC Fase I de denosumab biosimilar para el tratamiento de la osteoporosis. Front. Pharmacol., 24 January 2022 | https://t.co/9cGPuKwJz3
5,863 followers
New Research: Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects https://t.co/lCP3pDaZ58 #pharmacology